Genetic Screening and Teratogenic Exposures: Considerations in Caring for the Uterus Transplant Patient

*Division of Maternal-Fetal Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

†Women’s Health Institute, Division of Maternal-Fetal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

‡Department of Obstetrics and Gynecology, Prisma Health, Columbia, South Carolina

The authors declare that they have nothing to disclose.

Correspondence: Eileen Y. Wang, MD, Division of Maternal-Fetal Medicine, Hospital of the University of Pennsylvania, 2 Silverstein, Philadelphia, PA. E-mail: [email protected]

留言 (0)

沒有登入
gif